Arbutus Biopharma and Genevant Sciences have filed multiple patent infringement lawsuits against Pfizer and BioNTech over ...
Arbutus Biopharma (ABUS) and Genevant Sciences, a subsidiary of Roivant Sciences (ROIV), on Thursday announced the filing of three international lawsuits over a patent dispute related to Pfizer (PFE) ...
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of ...
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their ...
Arbutus Biopharma and its licensee Genevant filed three patent infringement lawsuits against Pfizer and BioNTech for its lipid nanoparticle technology. The clinical-stage biopharmaceutical company is ...
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech traded blows this week with rival Moderna as dueling decisions came down in the ...
The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
Zacks Investment Research on MSN
What to watch in Pfizer's non-oncology portfolio this earnings season
Pfizer PFE will announce its second-quarter 2026 earnings on Aug. 4, and investors will be watching the performance of its ...
A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make their COVID-19 vaccine. Siding with Moderna, an American pharmaceutical firm ...
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2026 on Tuesday, August 4, 2026. Additionally, the Company will host a conference ...
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results